Physician profile
Sameer Ahmed
NPI 1972725083
$882.11
in general payments reported to CMS, 2019-2025
12 companies · $464 in 2025
The $464 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.56 · 2020: $17.80 · 2022: $158 · 2023: $28.56 · 2024: $144 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $457.08 | 2022-2025 | Barostim Neo System |
| Abbvie INC. | $91.33 | 2024 | |
| Celgene Corporation | $81.09 | 2022-2023 | Reblozyl |
| Allergan, INC. | $56.83 | 2019-2020 | |
| Abbott Laboratories | $47.29 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $27.79 | 2022-2024 | Opdualag |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.25 | 2025 | Lifevest |
| Cook Medical LLC | $23.50 | 2025 | Rosen |
| Shionogi INC | $20.32 | 2024 | Fetroja |
| Scpharmaceuticals INC. | $20.10 | 2025 | |
| Daiichi Sankyo INC. | $17.43 | 2019 | |
| Merck Sharp & Dohme LLC | $13.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.